ABSTRACT Background/aims Numerous processes have been implicated as causes of punctal stenosis. Recent studies have highlighted inflammation in punctoplasty specimens in patients with punctal stenosis. Conjunctival biopsy has been suggested as a means to determine underlying aetiologies, although little is known regarding what conjunctival pathologies are associated with punctal stenosis. Our objective is to examine the pathological and immunological findings in conjunctival biopsy specimens in patients with presumed idiopathic punctal stenosis. Methods A retrospective chart review was performed at a single institution over a 5 year period of patients with presumed idiopathic punctal stenosis who underwent conjunctival biopsy for histopathological and/ or direct immunofluorescence (DIF) examination. Patients with known aetiologies of punctal stenosis were excluded. Results 23 patients met inclusion criteria. Conjunctival biopsies (n=36) from all 23 patients underwent histological examination. 35 specimens (97.2%) showed lymphocytic infiltrates. Two patients (8.7%) had findings suggestive of sarcoidosis. Conjunctival biopsies from 18 of the 23 patients were also evaluated by DIF. Nine patients (50.0%) had fibrinogen characteristics suggestive of lichen planus. There were no complications related to the conjunctival biopsy procedures. Conclusions Conjunctiva appears to be an excellent proxy in evaluating patients with presumed idiopathic punctal stenosis. The biopsy is safe and provides ample tissue. Clinically, abnormal tissue should be targeted, if available. 11 of the 23 patients in this study demonstrated findings consistent with underlying immunological disorders, suggesting that conjunctival biopsy may play a role in identifying underlying aetiologies of punctal stenosis. Knowledge of these underlying conditions impacted treatments for several patients.
INTRODUCTION
Despite its rarity in the general population, punctal stenosis may have a significantly higher incidence in specific patient populations. Many conditions and medications have been associated with acquired punctal stenosis. These include infectious causes, such as Actinomyces; autoimmune and inflammatory conditions, such as chronic blepharitis, ectropion and graft-versus-host disease; and both topical and systemic medications, such as taxanes and topical glaucoma medications. 1 The proposed pathophysiological mechanism of acquired punctal stenosis involves a chronic inflammatory process that leads to fibrosis and ultimately results in punctal occlusion. Until recently, there were scant histopathological data in the literature to corroborate this theory. Supporting evidence instead partly came from biopsies of the lower lacrimal drainage system in cases where there were obstructions in this area. The local and systemic associations of lower lacrimal drainage system obstruction, particularly when it occurs bilaterally, has significant overlap with those conditions mentioned previously that are associated with punctal stenosis. It was a logical next step to hypothesise that punctal specimens from cases of stenosis would have similar histopathological findings as those seen in the lower lacrimal drainage system. More recent literature has supported this theory, finding similar signs of chronic inflammation in the punctal tissue in cases of punctal stenosis. 2 3 These recent papers allow more confident correlations to be made between the aetiological processes and pharmacological agents associated with punctal stenosis, and the pathophysiological processes that lead to this stenosis. However, no current studies have examined the utility of histopathological and direct immunofluorescence (DIF) studies of conjunctival biopsies in patients with punctal stenosis. The conjunctiva is accessible with less clinical consequences of biopsy compared with the canaliculus and punctum, and provides a greater amount of tissue for examination. Further insight into the potential role of conjunctival biopsy in the evaluation of punctal stenosis could thus be quite valuable. Additionally, while there are many proposed aetiologies of punctal stenosis, some patients develop this condition despite a lack of any relevant disease or medication history. To date, no study has focused exclusively on patients with presumed idiopathic punctal stenosis.
This study proposes to expand upon the findings mentioned above by examining the histopathology and DIF of conjunctival biopsy specimens in patients with presumed idiopathic punctal stenosis.
MATERIALS AND METHODS
A retrospective chart review was performed of patients who presented to the University of Iowa Hospital and Clinics (UIHC) between January 2010 and January 2015 with presumed idiopathic epiphora, were clinically diagnosed with punctal stenosis and subsequently underwent conjunctival biopsy for histopathological and/or DIF examination. The biopsies were taken from the palpebral conjunctiva, between the inferior border of the tarsus and the fornix using Paufique forceps and Westcott scissors (surgical video available at http://webeye.ophth.uiowa.edu/eyeforum/ video/plastics/2/Conjunctival-biopsy.htm). Two biopsies were taken ipsilateral to the punctal stenosis; if bilateral disease was present, then a total of four biopsies were taken. Some patients only consented to unilateral biopsy. One specimen was sent for histopathological examination and one was sent for DIF examination. If clinically abnormal tissue was evident, then the histopathological specimen was sent from this area; however, this information was not documented in the patient record. The following data were collected: age, sex, laterality of punctal stenosis, biopsy date, DIF report, histopathology report, past medical history and treatments following biopsy. Histopathological examination was performed on 36 conjunctiva specimens using haematoxylin-eosin. DIF was performed on 27 conjunctiva specimens using antibodies for IgG, IgA, IgM, C3 and fibrinogen. Appropriate controls were used for all antibodies. Patients with known systemic or pharmacological aetiologies for punctal stenosis were excluded. These aetiologies have been described in the literature previously 1 and include autoimmune disease, infectious agents, eyelid malposition, chronic blepharitis, topical ocular therapy and systemic chemotherapy. Institutional review board approval was obtained from UIHC with a waiver of consent due to the retrospective nature of the study.
RESULTS
Twenty-three patients met inclusion criteria for this study (table 1) . Twenty of the 23 patients (87.0%) were female. The mean age was 56.6 years, with a range of 37-85 years. Bilateral disease was present in 21 of the 23 patients (91.3%). None of the patients were noted preoperatively to have clinically significant conjunctival inflammation or pathology. Conjunctival biopsies from all 23 patients, representing 36 specimens, underwent histological examination. All patients underwent nasolacrimal duct probing with stent placement and punctoplasty at the time of conjunctival biopsy. There were no complications related to the conjunctival biopsy. The average volume of excised tissue was 30.3 mm 3 . Thirty-five of 36 specimens (97.2%) showed stromal lymphocytic infiltrates. Three patients (13.0%) displayed evidence of chronic granulomatous inflammation. Two of these three patients (cases 14 and 16) had findings that were suggestive of sarcoidosis. Both patients required multiple surgeries for treatment. Case 14 also presented with chronic cough but further evaluation following the conjunctival biopsy found no evidence of granulomas on lung biopsy. ACE and lysozyme levels were also normal in this patient. Case 16 did not present with any systemic symptoms but was found to have an elevated ACE level.
Conjunctival biopsies from 18 of the 23 patients, representing 27 specimens, were also evaluated by DIF. Four of the 18 patients (22.2%) (cases 1, 8, 13 and 19) had no identifiable deposition along the basement membrane zone (BMZ) after staining with the antibodies listed previously. Five patients (27.8%) (cases 2, 4, 9, 15 and 18) displayed fine linear deposition of fibrin or fibrinogen along the BMZ with no deposition of immunoglobulin or complement C3. Nine patients (50.0%) (cases 3, 5, 7, 10, 17, 20, 21, 22 and 23) had depositions of fibrinogen-described as being shaggy, discontinuous, duplicative, globular and/or split-along the BMZ (figure 1). These findings were described as being consistent with a lichenoid reactive process, such as lichen planus (LP). Seven of these nine patients (77.8%) were female, and all nine patients (100%) presented with bilateral punctal stenosis.
Of these nine patients with DIF findings consistent with LP, none had a history of skin or mucosal lesions or previous diagnoses of LP. Seven of the nine patients (cases 5, 10, 17, 20, 21, 22 and 23) were started on ciclosporin A 0.05% eyedrops (Restasis) after the results of the DIF were obtained.
DISCUSSION
Many aetiological processes and pharmacological agents have been associated with the acquisition of punctal stenosis, yet until two recent studies, 2 3 little was known about the underlying pathophysiological processes. This study further expands upon those previous findings while also examining the utility of conjunctival biopsy in patients with presumed idiopathic punctal stenosis.
Both recent studies examined punctoplasty specimens 2 3 and showed evidence of chronic inflammation in the majority of specimens. Port et al 2 examined punctal histopathology in patients with punctal stenosis and found that over 83% of these specimens displayed signs-such as chronic inflammation, fibrosis and squamous metaplasia-that were consistent with an inflammatory process. Presumed punctal stenosis aetiologies in these patients included chronic blepharitis, Meibomian gland dysfunction, and topical and chemotherapeutical medications. Ali et al 3 found fibrosis, again suggesting a chronic inflammatory process, in 100% of their punctal specimens from patients with undefined aetiologies of punctal stenosis. Our study, in which 97.2% of conjunctival specimens displayed inflammatory infiltrates, further corroborates both of these prior two studies and the current proposed mechanism of acquired punctal stenosis, which involves a chronic inflammatory process leading to fibrosis and punctal occlusion. Importantly, our study population was purely patients with presumed idiopathic punctal stenosis.
The indication for biopsy in these patients was the finding of punctal stenosis without any known aetiology. Although biopsy is not routine, this was based on the hypothesis that the aetiology of the punctal stenosis would be reflected in the adjacent conjunctival tissue. Known causes of punctal stenosis that were not elicited in the history or examination of the patient are known to have histopathological and immunopathological findings in the conjunctiva, such as ocular cicatricial pemphigoid and sarcoidosis. This was the basis for performing conjunctival biopsies on these patients with presumed idiopathic punctal stenosis.
Two patients (cases 14 and 16) were found to have conjunctival histopathology suggestive of sarcoidosis, an inflammatory disorder that most commonly affects the lungs and lymph nodes. However, it can also affect the eyes and orbit, most commonly manifesting as anterior uveitis. As blind biopsies to screen for sarcoidosis are generally low yield for positive results, the authors recommend that conjunctival biopsy for histopathology be directed towards clinically abnormal tissue, if available. Although none of our patients were preoperatively noted to have significant conjunctival pathology, one could postulate that other, more sensitive clinical modalities could have detected subclinical conjunctival pathology that was not noted by the authors. Anecdotally, if abnormal tissue was noted at the time of biopsy, this tissue was targeted for biopsy but this information was not documented in the patient record. Involvement of the lacrimal drainage system in sarcoidosis appears to be quite rare, with one paper reporting 1.8% (n=281) of patients with ocular sarcoidosis having lacrimal obstruction, most commonly the nasolacrimal duct. 4 Patients with obstruction of the lacrimal system associated with sarcoidosis are notoriously difficult to treat, often requiring multiple surgical procedures before symptoms are resolved. Both patients in our study underwent several lacrimal surgeries to treat their epiphora. Of the 18 patients who underwent conjunctival DIF examination, 5 patients were found to have linear fibrin or fibrinogen markings along the BMZ, while nine others had BMZ fibrinogen markings described as shaggy, discontinuous, duplicative and/or split. Unlike in skin and the oral mucosa, where the presence of subepithelial fibrinogen is abnormal and in itself very suggestive of LP, subepithelial fibrinogen in the conjunctiva has been shown to be a normal feature. 5 With conjunctival specimens, it is vital to not look just for the presence or absence of fibrinogen, but rather its morphology. A fibrinogen layer with spikes, spurs, fragmentation, reduplication or a shaggy appearance is more likely to be consistent with a diagnosis of LP. [6] [7] [8] Therefore, the five patients with linear markings most likely display only non-specific inflammation, whereas the other nine patients show morphology that is indicative of a lichenoid process. LP, a mucocutaneous autoinflammatory disease, most commonly affects the skin and oral mucosa. Conjunctival involvement with LP is a relatively rare feature of the disease, with 64 cases described in the literature and the vast majority of patients presenting with cicatricial changes. 5 9-24 Even more uncommonly reported is LP with lacrimal drainage system involvement. Only 11 such patients have been described in various case reports and series 9 10 before Durrani et al 14 performed a retrospective review of 184 patients with canalicular obstruction. The authors found that eight of these patients had histories of systemic LP, with canalicular tissue biopsy showing changes also consistent with LP. These results led the authors to advise clinicians to be suspicious for LP in cases of bilateral canalicular obstruction without the presence of other risk factors. However, all these previous reports of lacrimal obstruction secondary to LP involved patients with some kind of systemic manifestations. The one exception is the study by Brewer et al 17 in which 3 of 11 patients had LP isolated to the conjunctiva, only one of which was also described to have punctal stenosis. The nine relevant patients in our study did not have any other associated mucocutaneous or skin findings. These cases seem to be examples of LP isolated to the conjunctiva and lacrimal drainage system leading to punctal stenosis without other systemic systemic or clinical conjunctival findings. While there are three published reports describing six patients with isolated LP leading to cicatricial conjunctivitis, [14] [15] [16] these cases centred on the conjunctival findings without description of the examination of the lacrimal system.
The scarcity of similar cases in the existing literature raises the question of whether this entity is an underdiagnosed disease or if other classes of conjunctival inflammation can also appear similar under DIF. If these cases do represent true instances of LP, they suggest that isolated LP to the conjunctiva may be a relatively common cause of punctal stenosis in patients without other risk factors. Thus, patients meeting these criteria may benefit from prompt histopathological and DIF examination.
Treatment for patients with systemic LP with ocular symptoms has primarily consisted of oral ciclosporin. 9 In a report describing two patients with LP isolated only to the conjunctiva, the patients were started on topical ciclosporin A 0.05%. 22 The authors found that this topical medication adequately controlled inflammation and the patients' symptoms. Given the lack of systemic symptoms in our patients, systemic ciclosporin use was not indicated; seven of our patients (cases 5, 10, 17, 20, 21, 22 and 23) were started on topical ophthalmic ciclosporin A 0.05%. Cases 10, 17, 22 and 23 had marked improvements in epiphora symptoms at follow-up time ranging from 4 to 16 months. The effects of topical ciclosporin on cases 5, 20 and 21 are still pending at this time.
In total, of the 23 patients in this study with presumed idiopathic punctal stenosis and epiphora, 11 (47.8%) were found to have underlying aetiologies for their presentation. This information suggests the importance of performing a thorough work up, including both histopathological and DIF examination, in these patients with presumed idiopathic punctal stenosis.
Diagnosis may impact the implementation of medical therapies or the success rate of surgical therapies.
The utility of conjunctival biopsy in patients with punctal stenosis was also examined in this study. The previous studies finding histopathological evidence of chronic inflammation in these patients 2 3 included punctal specimens. However, as noted previously, conjunctiva provides a greater amount of tissue for sampling. That conjunctival biopsies in this study displayed similar findings with regard to inflammation as those seen in the previous punctal specimens, suggesting that conjunctival biopsies may indeed be a safe and effective proxy in patients with punctal stenosis. The use of adjacent tissue to the puncta rather than the punctal tissue itself is a limitation to the study. The main advantage of using the conjunctiva is the volume of tissue available for histopathology and immunohistochemistry, compared with the relatively scarce amount of tissue available from the puncta. Whether these pathological changes observed in this population with presumed idiopathic punctal stenosis would be observed in tissue from the canaliculus, lacrimal sac, nasolacrimal duct or nasal mucosa is speculative, and additional studies would be needed to examine this.
Additional limitations to this study include the retrospective method and the lack of a control group, consisting of histopathological and DIF examination of conjunctiva from patients without punctal stenosis, although the literature has already described the findings in normal and inflamed conjunctiva. Another weakness is the lack of adjunctive examination of the conjunctiva preoperatively to determine if subtle, subclinical abnormalities were present that were not observed by the authors. Future studies are needed to determine the characteristic DIF findings in other aetiologies of conjunctival inflammation, which will allow us to more confidently diagnose ocular adnexal LP via conjunctival DIF. 
